Rajputana Bio.

  • Market Cap: Micro Cap
  • Industry: Miscellaneous
  • ISIN: INE0VHU01019
  • NSEID: RAJPUTANA
  • BSEID:
INR
250.05
0.00 (0.00%)
BSENSE

Dec 04

BSE+NSE Vol: 3500

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

3.5 k (66.67%) Volume

Shareholding (Sep 2025)

FII

0.03%

Held by 1 FIIs

DII

2.84%

Held by 0 DIIs

Promoter

65.77%

Who are the top shareholders of the Rajputana Bio.?

06-Jun-2025

The top shareholders of Rajputana Bio include promoter Sudeep Soni with 22.45%, followed by Nine Alps Trust-nine Alps Opportunity Fund at 3.38%, and individual investors holding 24.83%. There are no pledged promoter holdings or mutual funds invested in the company.

The top shareholders of Rajputana Bio include the promoters, who hold the majority of the shares. The promoter with the highest holding is Sudeep Soni, who owns 22.45% of the company. In terms of public shareholders, the highest is Nine Alps Trust-nine Alps Opportunity Fund, with a holding of 3.38%. Additionally, individual investors collectively hold 24.83% of the shares. There are also two foreign institutional investors (FIIs) that hold a combined 0.48% of the company. Notably, there are no pledged promoter holdings and no mutual funds currently invested in the company.

Read More

When is the next results date for Rajputana Bio.?

06-Jun-2025

No Upcoming Board Meetings

Has Rajputana Bio. declared dividend?

06-Jun-2025

No Dividend History Available

Who are the peers of the Rajputana Bio.?

04-Jun-2025

Peers of Rajputana Bio. include Coal India, Doms Industries, Sandur Manganese, and others. Doms Industries leads in 1-year returns at 32.62%, while Rajputana Bio. has a return of 0.00%.

Peers: The peers of Rajputana Bio. are Coal India, Doms Industries, Sandur Manganese, Navneet Educat., Flair Writing, Nidhi Granites, Crayons Advertis, Pramara Promotio, Urban Enviro, Aesthetik.<BR><BR>Quality Snapshot: Excellent management risk is observed at Coal India, Sandur Manganese, and Urban Enviro, while Good management risk is found at Doms Industries, Crayons Advertis, and Aesthetik. Average management risk is present at Navneet Educat., Flair Writing, and Pramara Promotio, while Below Average management risk is seen at Nidhi Granites. Growth is Excellent for Coal India, Doms Industries, Sandur Manganese, Urban Enviro, and Aesthetik, while Average growth is noted at Nidhi Granites and Good growth at Pramara Promotio. Below Average growth is observed at Navneet Educat. and Flair Writing. Capital Structure is Excellent for Coal India, Doms Industries, Sandur Manganese, Flair Writing, Crayons Advertis, and the rest.<BR><BR>Return Snapshot: Doms Industries has the highest 1-year return at 32.62%, while Coal India has the lowest at -23.33%. Rajputana Bio.'s 1-year return is 0.00%, which is lower than Doms Industries and higher than Coal India. Additionally, Nidhi Granites is the only peer with a negative six-month return.

Read More

What is the technical trend for Rajputana Bio.?

09-Jun-2025

As of June 2, 2025, Rajputana Bio's technical trend is neutral, showing a shift from mildly bearish to sideways, with no clear signals from key indicators like MACD, KST, and RSI.

As of 2 June 2025, the technical trend for Rajputana Bio has changed from mildly bearish to sideways. The weekly MACD and KST show no clear signals, while the monthly indicators are also lacking definitive trends. The RSI on the weekly timeframe indicates no signal, and the Dow Theory suggests a mildly bearish stance on the weekly chart. The Bollinger Bands are indicating a sideways movement on both weekly and monthly timeframes. Overall, the current technical stance is neutral, reflecting a lack of strong directional momentum.

Read More

What does Rajputana Bio. do?

17-Jul-2025

Rajputana Biodiesel Limited, a micro-cap company incorporated in 2016, operates in the biodiesel sector and recently transitioned to a public company. It has a market cap of INR 156 Cr, with key metrics including a P/E ratio of 27.00 and a return on equity of 42.02%.

Overview: <BR>Rajputana Biodiesel Limited operates in the miscellaneous industry as a micro-cap company.<BR><BR>History: <BR>The company was incorporated in 2016 under the name Rajputana Biodiesel Systems Private Limited. It later converted from a Private Limited Company to a Public Limited Company, adopting the name Rajputana Biodiesel Limited, with a fresh Certificate of Incorporation issued on July 8, 2024. Revenue and profit data for the latest quarter are not available.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 156 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 27.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 1.08 <BR>Return on Equity: 42.02% <BR>Price-to-Book: 11.01 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Read More

How big is Rajputana Bio.?

24-Jul-2025

As of 24th July, Rajputana Biodiesel Ltd has a market capitalization of 156.00 Cr, classifying it as a Micro Cap company, with Shareholder's Funds of 14.22 Cr and Total Assets of 42.30 Cr; however, there is no valid financial data available for net sales or net profit for the latest four quarters.

As of 24th July, <BR><BR>Market Cap: Rajputana Biodiesel Ltd has a market capitalization of 156.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for net sales or net profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2024, with Shareholder's Funds amounting to 14.22 Cr and Total Assets valued at 42.30 Cr.

Read More

Is Rajputana Bio. overvalued or undervalued?

29-Aug-2025

As of August 28, 2025, Rajputana Bio. is considered very expensive and overvalued with a high PE ratio of 30.61, a Price to Book Value of 12.86, and an EV to EBITDA of 22.18, despite a recent 16.38% return, it has underperformed year-to-date with a 16.97% decline compared to the Sensex's 3.62% gain.

As of 28 August 2025, Rajputana Bio. has moved from a fair valuation to very expensive. The company is currently overvalued, as indicated by its high PE ratio of 30.61, a Price to Book Value of 12.86, and an EV to EBITDA of 22.18. These ratios suggest that the stock is trading at a premium compared to its earnings and book value.<BR><BR>In comparison to its peers, Rajputana Bio.'s PE ratio is significantly lower than Solar Industries, which has a PE of 99.06, but higher than Godrej Industries, which stands at 41.86. Additionally, the PEG ratio of Rajputana Bio. is 0.00, indicating no growth relative to its price, which further supports the conclusion of overvaluation. Notably, while Rajputana Bio. has experienced a 16.38% return over the past month, it has underperformed on a year-to-date basis, down 16.97%, contrasting with the Sensex's 3.62% gain.

Read More

How has been the historical performance of Rajputana Bio.?

15-Nov-2025

Rajputana Bio's historical performance shows growth in net sales and profits, with net sales increasing to 67.31 crore and profit after tax rising to 5.92 crore for the fiscal year ending March 2025. However, cash flow from operating activities was negative at -15.00 crore, indicating challenges in cash flow management.

Answer:<BR>The historical performance of Rajputana Bio shows a positive trend in key financial metrics over the past year.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Rajputana Bio reported net sales of 67.31 crore, an increase from 53.46 crore in March 2024. The total operating income also rose to 67.31 crore from 53.46 crore, while total expenditure increased to 58.37 crore from 45.75 crore. This resulted in an operating profit (PBDIT) of 10.23 crore, up from 7.93 crore the previous year. Profit before tax improved to 7.53 crore from 6.14 crore, leading to a profit after tax of 5.92 crore, compared to 4.56 crore in the prior year. The company’s earnings per share slightly decreased to 8.42 from 8.89, while the PAT margin improved to 8.8% from 8.53%. On the balance sheet, total assets grew to 60.49 crore from 42.30 crore, with total liabilities also increasing to 60.49 crore from 42.30 crore. Cash flow from operating activities showed a negative trend at -15.00 crore, though financing activities provided a net inflow of 15.00 crore. Overall, Rajputana Bio's financial performance indicates growth in sales and profits, despite challenges in cash flow management.

Read More

Why is Rajputana Bio. falling/rising?

05-Dec-2025

As of 04-Dec, Rajputana Biodiesel Ltd's stock price is at 250.05, down 1.32%, and has significantly underperformed the sector and benchmark indices year-to-date. Despite increased investor participation, the stock remains in a downward trend, lower than several key moving averages.

As of 04-Dec, Rajputana Biodiesel Ltd's stock price is falling, currently at 250.05, which reflects a decrease of 3.35 or 1.32%. The stock has underperformed its sector today by 1.11%. Over the past week, the stock has declined by 0.85%, while the benchmark Sensex has only decreased by 0.69%. Year-to-date, the stock has seen a significant drop of 20.15%, contrasting sharply with the Sensex's gain of 10.10%. <BR><BR>Despite being higher than the 200-day moving averages, the stock is lower than the 5-day, 20-day, 50-day, and 100-day moving averages, indicating a weaker short-term performance. However, there has been a rise in investor participation, with a delivery volume increase of 17.65% against the 5-day average on December 3rd, suggesting some interest in trading the stock. Nonetheless, these factors have not been sufficient to counteract the overall downward trend in the stock price.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

INR 176 Cr (Micro Cap)

stock-summary
P/E

29.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.27

stock-summary
Return on Equity

12.98%

stock-summary
Price to Book

3.82

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.08%
0%
-6.08%
6 Months
3.5%
0%
3.5%
1 Year
-12.54%
0%
-12.54%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Rajputana Bio. for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News

Why is Rajputana Bio. falling/rising?

Recent Price Movement and Market Context

Rajputana Biodiesel’s shares declined by ₹2.05 during the trading session on 24 November, closing at ₹261.95. This drop contrasts with the broader market, where the Sensex recorded a modest gain of 0.64% over the past month. The stock’s one-week return of -1.15% also underperformed the Sensex’s -0.21% over the same period, signalling relative weakness in investor sentiment towards the company.

More notably, the year-to-date (YTD) performance of Rajputana Biodiesel reveals a significant decline of 16.35%, while the Sensex has gained 9.79% in the same timeframe. This stark divergence highlights the stock’s struggles amid a generally positive market environment, suggesting company-specific factors or sectoral headwinds may be weigh...

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
25.90%
EBIT Growth (5y)
11.79%
EBIT to Interest (avg)
5.54
Debt to EBITDA (avg)
1.57
Net Debt to Equity (avg)
0.31
Sales to Capital Employed (avg)
1.17
Tax Ratio
21.38%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
2.87%
ROCE (avg)
14.45%
ROE (avg)
23.82%
Valuation key factors
Factor
Value
P/E Ratio
29
Industry P/E
0
Price to Book Value
3.82
EV to EBIT
23.37
EV to EBITDA
21.07
EV to Capital Employed
3.22
EV to Sales
2.80
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
13.77%
ROE (Latest)
12.98%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
Bollinger Bands
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (0.03%)

Promoter with highest holding

Sudeep Soni (22.5%)

Highest Public shareholder

Nine Alps Trust-nine Alps Opportunity Fund (2.54%)

Individual Investors Holdings

27.74%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Rajputana Bio."
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 160.58% vs -48.84% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 471.70% vs -78.19% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "59.36",
          "val2": "22.78",
          "chgp": "160.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.28",
          "val2": "2.82",
          "chgp": "193.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.67",
          "val2": "0.92",
          "chgp": "-27.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6.06",
          "val2": "1.06",
          "chgp": "471.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.95%",
          "val2": "12.38%",
          "chgp": "1.57%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Rajputana Bio."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -12.53% vs 129.69% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -16.74% vs 172.19% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "47.03",
          "val2": "53.77",
          "chgp": "-12.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6.45",
          "val2": "7.75",
          "chgp": "-16.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.69",
          "val2": "1.11",
          "chgp": "52.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.07",
          "val2": "-0.18",
          "chgp": "61.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "3.83",
          "val2": "4.60",
          "chgp": "-16.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.71%",
          "val2": "14.41%",
          "chgp": "-0.70%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary
Sep'25
Mar'25
Change(%)
Net Sales
59.36
22.78
160.58%
Operating Profit (PBDIT) excl Other Income
8.28
2.82
193.62%
Interest
0.67
0.92
-27.17%
Exceptional Items
0.00
0.00
Consolidate Net Profit
6.06
1.06
471.70%
Operating Profit Margin (Excl OI)
13.95%
12.38%
1.57%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 160.58% vs -48.84% in Mar 2025

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 471.70% vs -78.19% in Mar 2025

Annual Results Snapshot (Standalone) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
47.03
53.77
-12.53%
Operating Profit (PBDIT) excl Other Income
6.45
7.75
-16.77%
Interest
1.69
1.11
52.25%
Exceptional Items
-0.07
-0.18
61.11%
Standalone Net Profit
3.83
4.60
-16.74%
Operating Profit Margin (Excl OI)
13.71%
14.41%
-0.70%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is -12.53% vs 129.69% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is -16.74% vs 172.19% in Mar 2024

stock-summaryCompany CV
About Rajputana Biodiesel Ltd stock-summary
stock-summary
Rajputana Biodiesel Ltd
Micro Cap
Miscellaneous
Rajputana Biodiesel Limited was incorporated on November 10, 2016 under the name and style of `Rajputana Biodiesel Systems Private Limited, pursuant to a Certificate of Incorporation issued by the Registrar of Companies, Jaipur. Company status was converted from a Private Limited Company to Public Limited Company with the the name 'Rajputana Biodiesel Limited' and a fresh Certificate of Incorporation dated July 08th, 2024 was issued to Company by the Central Processing Centre, Manesar.
Company Coordinates stock-summary
Icon
No Company Details Available